Sicart Associates’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-419
| Closed | -$403K | – | 78 |
|
|
2024
Q1 | $403K | Hold |
419
| – | – | 0.15% | 57 |
|
|
2023
Q4 | $368K | Hold |
419
| – | – | 0.14% | 54 |
|
|
2023
Q3 | $345K | Hold |
419
| – | – | 0.14% | 53 |
|
|
2023
Q2 | $301K | Sell |
419
-48
| -10% | -$34.5K | 0.12% | 55 |
|
|
2023
Q1 | $384K | Sell |
467
-3
| -0.6% | -$2.47K | 0.15% | 54 |
|
|
2022
Q4 | $339K | Hold |
470
| – | – | 0.12% | 60 |
|
|
2022
Q3 | $324K | Sell |
470
-56
| -11% | -$38.6K | 0.11% | 60 |
|
|
2022
Q2 | $311K | Sell |
526
-12
| -2% | -$7.1K | 0.1% | 62 |
|
|
2022
Q1 | $376K | Sell |
538
-382
| -42% | -$267K | 0.1% | 63 |
|
|
2021
Q4 | $591K | Sell |
920
-128
| -12% | -$82.2K | 0.15% | 61 |
|
|
2021
Q3 | $634K | Sell |
1,048
-15
| -1% | -$9.07K | 0.17% | 58 |
|
|
2021
Q2 | $594K | Hold |
1,063
| – | – | 0.14% | 66 |
|
|
2021
Q1 | $503K | Buy |
+1,063
| New | +$503K | 0.13% | 66 |
|